Jan 6, 2026 08:18AM Evercore ISI on Vaxcyte (PCVX): 'vaccine shakeup, but there's no change to PCV recs...'

Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026

Dec 9, 2025 04:40AM Jefferies Reiterates Buy Rating on Vaxcyte (PCVX)

Nov 19, 2025 05:23AM Vaxcyte (PCVX) PT Raised to $77 at Leerink Partners

Nov 4, 2025 05:54PM Vaxcyte, Inc. (PCVX) Misses Q3 EPS by 32c

Oct 1, 2025 01:20PM Canaccord #1 Key Risk to AxoGen, Inc. (AXGN): 'the FDA running out of carryover funding and needing to halt work'

Oct 1, 2025 01:13PM FDA on Operations During Shutdown: 'FDA will not be able to accept any regulatory submissions for FY 2026 that require a fee payment'

Sep 30, 2025 08:35AM Vaxcyte partners with Thermo Fisher for $1B North Carolina manufacturing

Sep 12, 2025 05:54AM Goldman Sachs Starts Vaxcyte (PCVX) at Neutral

Aug 8, 2025 08:34AM Vaxcyte (PCVX) PT Lowered to $116 at Guggenheim

Aug 6, 2025 06:22PM Vaxcyte, Inc. (PCVX) Misses Q2 EPS by 5c

Jun 10, 2025 06:56AM Cantor Fitzgerald Reiterates Overweight Rating on Vaxcyte (PCVX)

May 8, 2025 06:22AM Vaxcyte, Inc. (PCVX) Reports In-Line Q1 EPS

May 1, 2025 08:01AM Vaxcyte, Inc (PCVX) Appoints Olivier Brandicourt to its Board

Apr 22, 2025 07:22AM Cantor Fitzgerald Starts Vaxcyte (PCVX) at Overweight

Apr 1, 2025 05:07AM Vaxcyte (PCVX) PT Lowered to $100 at Goldman Sachs

Mar 31, 2025 10:04AM Jefferies on Vaxcyte (PCVX): 'this data increasing PCVX's fundamental value'

Mar 31, 2025 08:05AM Guggenheim Reiterates Buy Rating on Vaxcyte (PCVX)

Mar 31, 2025 07:00AM Vaxcyte, Inc (PCVX) Announces Positive Topline Results from VAX-24 Infant Phase 2 Dose-Finding Study

Mar 3, 2025 01:28PM Mizuho Reiterates Outperform Rating on Vaxcyte (PCVX), PT $163

Feb 24, 2025 05:04AM BTIG Reiterates Buy Rating on Vaxcyte (PCVX)

Feb 17, 2025 05:38PM Kuehn Law Encourages Investors of Vaxcyte, Inc. to Contact Law Firm

Feb 5, 2025 08:02AM Vaxcyte (PCVX) Advances to Second Stage of Ongoing Phase 2 Study Evaluating VAX-31 for the Prevention of Invasive Pneumococcal Disease in Infants

Dec 20, 2024 06:19AM Goldman Sachs Starts Vaxcyte (PCVX) at Buy

Dec 19, 2024 02:00PM 4 themes and 4 key biotech stocks for 2025: Jefferies

Nov 12, 2024 07:31AM Vaxcyte, Inc (PCVX) Provides Regulatory Updates on VAX-31 Pediatric and Adult Programs

Nov 6, 2024 06:13AM Vaxcyte (PCVX) PT Raised to $146 at Jefferies

Nov 6, 2024 05:59AM Leerink Partners Reiterates Outperform Rating on Vaxcyte (PCVX)

Nov 5, 2024 04:50PM Vaxcyte, Inc. (PCVX) Tops Q3 EPS by 27c

Oct 24, 2024 12:03PM BTIG Reiterates Buy Rating on Vaxcyte (PCVX)

Oct 10, 2024 08:22AM TD Cowen Reiterates Buy Rating on Vaxcyte (PCVX)

Sep 10, 2024 06:37AM Vaxcyte (PCVX) PT Raised to $163 at Mizuho

Sep 6, 2024 04:06PM Vaxcyte, Inc (PCVX) Closes $1.5B Offering

Sep 5, 2024 06:13AM Vaxcyte, Inc (PCVX) Prices $1.3B Share Offering at $103/sh

Sep 4, 2024 05:27AM Vaxcyte (PCVX) PT Raised to $140 at BofA Securities

Sep 3, 2024 04:10PM TD Cowen Reiterates Buy Rating on Vaxcyte (PCVX)

Sep 3, 2024 04:02PM Vaxcyte (PCVX) Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants

Sep 3, 2024 02:42PM Vaxcyte, Inc (PCVX) September 105 puts active as share price up 37%

Sep 3, 2024 11:48AM Vaxcyte (PCVX) PT Raised to $160 at BTIG

Sep 3, 2024 09:34AM Vaxcyte (PCVX) PT Raised to $129 at Jefferies

Sep 3, 2024 09:33AM Vaxcyte (PCVX) PT Raised to $129 at Jefferies

Sep 3, 2024 08:43AM Vaxcyte (PCVX) Reports Positive Topline Data from Phase 1/2 Study of VAX-31, its 31-Valent Pneumococcal Conjugate Vaccine Candidate, in Adults Aged 50 and Older

Sep 3, 2024 08:25AM Mizuho Reiterates Outperform Rating on Vaxcyte (PCVX)

Aug 7, 2024 12:15PM BTIG Reiterates Buy Rating on Vaxcyte (PCVX)

Jul 1, 2024 10:42AM TD Cowen Reiterates Buy Rating on Vaxcyte (PCVX)

Jun 21, 2024 05:33AM BofA Securities Reiterates Buy Rating on Vaxcyte (PCVX)

Apr 5, 2024 01:00PM M&A watch: 3 biotech companies that are most likely to be acquired - Needham

Feb 9, 2024 08:00PM 4 small and mid-cap biopharma stocks to own according to BofA